ClinicalTrials.Veeva

Menu

Risk Stratification for Venous Thromboembolism in Hospitalized Medical Patients (RISE)

I

Insel Gruppe AG, University Hospital Bern

Status

Completed

Conditions

Pulmonary Embolism
Venous Thromboembolism
Hospital Acquired Condition
Embolism and Thrombosis
Deep Vein Thrombosis
Mobility Limitation
Venous Thromboses

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

Hospital-acquired venous thromboembolism (HA-VTE) is one of the leading preventable causes of in-hospital mortality, but prevention of VTE in hospitalized medical patients remains challenging, as preventive measures such as pharmacological thromboprophylaxis (TPX) need to be tailored to individual thrombotic risk.

The broad objective of this project is to improve VTE prevention strategies in hospitalized medical patients by prospectively examining VTE risk factors (including mobility) and comparing existing risk assessment models.

Enrollment

1,353 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • Age ≥18 years
  • Admitted for hospitalization >24 hours on a general internal medicine ward
  • Informed consent as documented by signature

Exclusion criteria

  • Need for therapeutic anticoagulation (e.g., atrial fibrillation)
  • Life expectancy <30 days
  • Insufficient proficiency of the German or French language
  • Unwilling to provide informed consent
  • Prior enrolment in the study

Trial contacts and locations

3

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems